Sign in
4

Changes in Ownership

Teladoc Health, Inc. Filed Acc 0001415889-22-002589

CHIEF MARKETING OFFICER sold 2,858 shares at $70.24 ($200,743)

  • CHIEF MARKETING OFFICER acquired 7,670 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Verstraete Stephany CHIEF MARKETING OFFICER 2022-03-02 Option exercise +1,808 24,086 D
Verstraete Stephany CHIEF MARKETING OFFICER 2022-03-02 Option exercise +3,074 27,160 D
Verstraete Stephany CHIEF MARKETING OFFICER 2022-03-02 Option exercise +773 27,933 D
Verstraete Stephany CHIEF MARKETING OFFICER 2022-03-02 Option exercise +1,147 29,080 D
Verstraete Stephany CHIEF MARKETING OFFICER 2022-03-02 Option exercise +868 29,948 D
Verstraete Stephany CHIEF MARKETING OFFICER 2022-03-03 Sale −2,858 $70.24 $200,743 27,090 D
Derivatives
Verstraete Stephany CHIEF MARKETING OFFICER 2022-03-02 Option exercise · Restricted Stock Units −1,808 1,807 D
Verstraete Stephany CHIEF MARKETING OFFICER 2022-03-02 Option exercise · Performance Stock Units −3,074 3,072 D
Verstraete Stephany CHIEF MARKETING OFFICER 2022-03-02 Grant or award · Performance Stock Units +1,545 1,545 D
Verstraete Stephany CHIEF MARKETING OFFICER 2022-03-02 Option exercise · Performance Stock Units −773 772 D
Verstraete Stephany CHIEF MARKETING OFFICER 2022-03-02 Option exercise · Restricted Stock Units −1,147 2,295 D
Verstraete Stephany CHIEF MARKETING OFFICER 2022-03-02 Grant or award · Performance Stock Units +2,602 2,602 D
Verstraete Stephany CHIEF MARKETING OFFICER 2022-03-02 Option exercise · Performance Stock Units −868 1,734 D
Open-market sales · 2,858 sh · avg $70.24 · $200,743
Loading xslF345X03/form4-03042022_030338.xml…